Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CERS – Cerus Corporation

CERS — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

5.57

Margin Of Safety %

Put/Call OI Ratio

0.13

EPS Next Q Diff

EPS Last/This Y

0.05

EPS This/Next Y

0.03

Price

2.56

Target Price

4.67

Analyst Recom

1

Performance Q

51.48

Upside

-168.4%

Beta

1.79

Ticker: CERS



18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-18CERS2.430.150.094555
2026-05-19CERS2.690.150.024601
2026-05-20CERS2.690.140.014867
2026-05-21CERS2.740.140.024907
2026-05-22CERS2.70.140.055016
2026-05-26CERS2.740.140.295047
2026-05-27CERS2.820.140.015069
2026-05-28CERS2.910.140.055072
2026-05-29CERS3.050.130.015162
2026-06-02CERS2.710.130.005285
2026-06-03CERS2.670.130.005339
2026-06-04CERS2.790.130.065340
2026-06-05CERS2.710.130.005353
2026-06-08CERS2.610.125.135558
2026-06-09CERS2.590.130.005603
2026-06-10CERS2.550.130.005614
2026-06-11CERS2.590.130.005644
2026-06-12CERS2.550.130.005609
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-18CERS2.4366.7- -0.03
2026-05-19CERS2.7066.7- -0.03
2026-05-20CERS2.6966.7- -0.03
2026-05-21CERS2.7466.7- -0.03
2026-05-22CERS2.7066.7- -0.03
2026-05-26CERS2.7466.7- -0.03
2026-05-27CERS2.8266.7- -0.03
2026-05-28CERS2.9166.7- -0.03
2026-05-29CERS3.0566.7- -0.03
2026-06-01CERS2.8466.7- -0.03
2026-06-02CERS2.7166.7- -0.03
2026-06-03CERS2.6666.7- -0.03
2026-06-04CERS2.7966.7- -0.03
2026-06-05CERS2.7266.7- -0.03
2026-06-08CERS2.6166.7- -0.03
2026-06-09CERS2.5966.7- -0.03
2026-06-10CERS2.5666.7- -0.03
2026-06-11CERS2.5966.7- -0.03
2026-06-12CERS2.5666.7- -0.03
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-18CERS-10.895.395.95
2026-05-19CERS-11.305.395.95
2026-05-20CERS-11.305.395.95
2026-05-21CERS-11.305.395.95
2026-05-22CERS-11.305.395.95
2026-05-26CERS-11.30-0.905.83
2026-05-27CERS-15.80-0.905.83
2026-05-28CERS-15.80-0.909.58
2026-05-29CERS-15.80-0.909.58
2026-06-02CERS-15.80-1.609.58
2026-06-03CERS-15.97-1.609.58
2026-06-04CERS-15.97-1.609.58
2026-06-05CERS-15.97-1.609.58
2026-06-08CERS-15.97-1.629.59
2026-06-09CERS-15.67-1.629.59
2026-06-10CERS-15.67-1.625.57
2026-06-11CERS-15.67-1.625.57
2026-06-12CERS-15.87-1.625.57
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS​

-0.01

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

-15.87

Institutional Transactions

-1.62

Beta

1.79

Average Sales Estimate Current Quarter

58

Average Sales Estimate Next Quarter

59

Fair Value

Quality Score

48

Growth Score

44

Sentiment Score

74

Actual DrawDown %

68.2

Max Drawdown 5-Year %

-85.4

Target Price

4.67

P/E

Forward P/E

PEG

P/S

2.37

P/B

7.59

P/Free Cash Flow

EPS

-0.05

Average EPS Est. Cur. Y​

-0.03

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-4.41

Relative Volume

0.98

Return on Equity vs Sector %

-41.7

Return on Equity vs Industry %

-25.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ CERS Healthcare
$2.56
📉
Swing / Pullback
Buy the dip on strong trends
63 /100
WATCH
Trend
14/20
Pullback
21/25
Volume
7/15
Valuation
11/20
TP/AR
2/10
Options
8/10
RSI
48.6
Range 1M
33.1%
Sup Dist
2.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
50 /100
WEAK
Momentum
9/25
Growth
28/30
Estimates
2/20
Inst/Vol
5/15
Options
6/10
EPS Yr
58.3%
EPS NY
90%
52W%
72.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +82.4% upside
Quality
5/30
Valuation
17/30
Growth
20/25
Stability
4/10
LT Trend
4/5
Upside
+82.4%
Quality
48
Click a card to see score breakdown Full Analysis →
Cerus Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 261
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.
CERS

Latest News

—
Caricamento notizie per CERS…
stock quote shares CERS – Cerus Corporation Stock Price stock today
news today CERS – Cerus Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CERS – Cerus Corporation yahoo finance google finance
stock history CERS – Cerus Corporation invest stock market
stock prices CERS premarket after hours
ticker CERS fair value insiders trading